Trial Profile
Proof-of-concept trial of intranasally administered influenza virus vaccine (FluGem)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Mar 2014
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Mucosis
- 24 Mar 2014 New trial record